The Parkinson anxiety scale (PAS): Development and validation of a new anxiety scale

Albert F G Leentjens, Kathy Dujardin, Gregory M Pontone, Sergio E. Starkstein, Daniel Weintraub, Pablo Martinez-Martin

Research output: Contribution to journalArticle

Abstract

Existing anxiety rating scales have limited construct validity in patients with Parkinson's disease (PD). This study was undertaken to develop and validate a new anxiety rating scale, the Parkinson Anxiety Scale (PAS), that would overcome the limitations of existing scales. The general structure of the PAS was based on the outcome of a Delphi procedure. Item selection was based on a canonical correlation analysis and a Rasch analysis of items of the Hamilton Anxiety Rating Scale (HARS) and the Beck Anxiety Inventory (BAI) from a previously published study. Validation was done in a cross-sectional international multicenter study involving 362 patients with idiopathic PD. Patients underwent a single screening session in which the PAS was administered, along with the Hamilton Depression Rating Scale, the HARS, and the BAI. The Mini International Neuropsychiatric Interview was administered to establish Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnoses of anxiety and depressive disorders. The PAS is a 12-item observer or patient-rated scale with three subscales, for persistent, episodic anxiety and avoidance behavior. Properties for acceptability and reliability met predetermined criteria. The convergent and known groups validity was good. The scale has a satisfactory factorial structure. The area under the receiver operating characteristics curve and Youden index of the PAS are higher than that of existing anxiety rating scales. The PAS is a reliable and valid anxiety measure for use in PD patients. It is easy and brief to administer, and has better clinimetric properties than existing anxiety rating scales. The sensitivity to change of the PAS remains to be assessed.

Original languageEnglish (US)
Pages (from-to)1035-1043
Number of pages9
JournalMovement disorders : official journal of the Movement Disorder Society
Volume29
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Anxiety
Parkinson Disease
Avoidance Learning
Equipment and Supplies
Depressive Disorder
Anxiety Disorders
ROC Curve
Diagnostic and Statistical Manual of Mental Disorders
Multicenter Studies
Interviews
Depression

Keywords

  • 'non-motor' symptoms
  • Anxiety
  • Depression
  • Parkinson's disease
  • Rating scale

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

The Parkinson anxiety scale (PAS) : Development and validation of a new anxiety scale. / Leentjens, Albert F G; Dujardin, Kathy; Pontone, Gregory M; Starkstein, Sergio E.; Weintraub, Daniel; Martinez-Martin, Pablo.

In: Movement disorders : official journal of the Movement Disorder Society, Vol. 29, No. 8, 2014, p. 1035-1043.

Research output: Contribution to journalArticle

Leentjens, Albert F G ; Dujardin, Kathy ; Pontone, Gregory M ; Starkstein, Sergio E. ; Weintraub, Daniel ; Martinez-Martin, Pablo. / The Parkinson anxiety scale (PAS) : Development and validation of a new anxiety scale. In: Movement disorders : official journal of the Movement Disorder Society. 2014 ; Vol. 29, No. 8. pp. 1035-1043.
@article{d207eb6a4bd94488b07608c0e2404db7,
title = "The Parkinson anxiety scale (PAS): Development and validation of a new anxiety scale",
abstract = "Existing anxiety rating scales have limited construct validity in patients with Parkinson's disease (PD). This study was undertaken to develop and validate a new anxiety rating scale, the Parkinson Anxiety Scale (PAS), that would overcome the limitations of existing scales. The general structure of the PAS was based on the outcome of a Delphi procedure. Item selection was based on a canonical correlation analysis and a Rasch analysis of items of the Hamilton Anxiety Rating Scale (HARS) and the Beck Anxiety Inventory (BAI) from a previously published study. Validation was done in a cross-sectional international multicenter study involving 362 patients with idiopathic PD. Patients underwent a single screening session in which the PAS was administered, along with the Hamilton Depression Rating Scale, the HARS, and the BAI. The Mini International Neuropsychiatric Interview was administered to establish Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnoses of anxiety and depressive disorders. The PAS is a 12-item observer or patient-rated scale with three subscales, for persistent, episodic anxiety and avoidance behavior. Properties for acceptability and reliability met predetermined criteria. The convergent and known groups validity was good. The scale has a satisfactory factorial structure. The area under the receiver operating characteristics curve and Youden index of the PAS are higher than that of existing anxiety rating scales. The PAS is a reliable and valid anxiety measure for use in PD patients. It is easy and brief to administer, and has better clinimetric properties than existing anxiety rating scales. The sensitivity to change of the PAS remains to be assessed.",
keywords = "'non-motor' symptoms, Anxiety, Depression, Parkinson's disease, Rating scale",
author = "Leentjens, {Albert F G} and Kathy Dujardin and Pontone, {Gregory M} and Starkstein, {Sergio E.} and Daniel Weintraub and Pablo Martinez-Martin",
year = "2014",
doi = "10.1002/mds.25919",
language = "English (US)",
volume = "29",
pages = "1035--1043",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - The Parkinson anxiety scale (PAS)

T2 - Development and validation of a new anxiety scale

AU - Leentjens, Albert F G

AU - Dujardin, Kathy

AU - Pontone, Gregory M

AU - Starkstein, Sergio E.

AU - Weintraub, Daniel

AU - Martinez-Martin, Pablo

PY - 2014

Y1 - 2014

N2 - Existing anxiety rating scales have limited construct validity in patients with Parkinson's disease (PD). This study was undertaken to develop and validate a new anxiety rating scale, the Parkinson Anxiety Scale (PAS), that would overcome the limitations of existing scales. The general structure of the PAS was based on the outcome of a Delphi procedure. Item selection was based on a canonical correlation analysis and a Rasch analysis of items of the Hamilton Anxiety Rating Scale (HARS) and the Beck Anxiety Inventory (BAI) from a previously published study. Validation was done in a cross-sectional international multicenter study involving 362 patients with idiopathic PD. Patients underwent a single screening session in which the PAS was administered, along with the Hamilton Depression Rating Scale, the HARS, and the BAI. The Mini International Neuropsychiatric Interview was administered to establish Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnoses of anxiety and depressive disorders. The PAS is a 12-item observer or patient-rated scale with three subscales, for persistent, episodic anxiety and avoidance behavior. Properties for acceptability and reliability met predetermined criteria. The convergent and known groups validity was good. The scale has a satisfactory factorial structure. The area under the receiver operating characteristics curve and Youden index of the PAS are higher than that of existing anxiety rating scales. The PAS is a reliable and valid anxiety measure for use in PD patients. It is easy and brief to administer, and has better clinimetric properties than existing anxiety rating scales. The sensitivity to change of the PAS remains to be assessed.

AB - Existing anxiety rating scales have limited construct validity in patients with Parkinson's disease (PD). This study was undertaken to develop and validate a new anxiety rating scale, the Parkinson Anxiety Scale (PAS), that would overcome the limitations of existing scales. The general structure of the PAS was based on the outcome of a Delphi procedure. Item selection was based on a canonical correlation analysis and a Rasch analysis of items of the Hamilton Anxiety Rating Scale (HARS) and the Beck Anxiety Inventory (BAI) from a previously published study. Validation was done in a cross-sectional international multicenter study involving 362 patients with idiopathic PD. Patients underwent a single screening session in which the PAS was administered, along with the Hamilton Depression Rating Scale, the HARS, and the BAI. The Mini International Neuropsychiatric Interview was administered to establish Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnoses of anxiety and depressive disorders. The PAS is a 12-item observer or patient-rated scale with three subscales, for persistent, episodic anxiety and avoidance behavior. Properties for acceptability and reliability met predetermined criteria. The convergent and known groups validity was good. The scale has a satisfactory factorial structure. The area under the receiver operating characteristics curve and Youden index of the PAS are higher than that of existing anxiety rating scales. The PAS is a reliable and valid anxiety measure for use in PD patients. It is easy and brief to administer, and has better clinimetric properties than existing anxiety rating scales. The sensitivity to change of the PAS remains to be assessed.

KW - 'non-motor' symptoms

KW - Anxiety

KW - Depression

KW - Parkinson's disease

KW - Rating scale

UR - http://www.scopus.com/inward/record.url?scp=84904392200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904392200&partnerID=8YFLogxK

U2 - 10.1002/mds.25919

DO - 10.1002/mds.25919

M3 - Article

C2 - 24862344

AN - SCOPUS:84904392200

VL - 29

SP - 1035

EP - 1043

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 8

ER -